Moreover, senescent prostate cancer cells, accumulating DNA damage induced by ionizing radiation and PARP inhibition, were killed by the Bcl-2 inhibitors navitoclax and ABT-737 [56]. The gene discussed is BCL2; the disease is prostate carcinoma.